The only bug is this part " Patients dosed with GALNS at 2 mg/kg every other week did not show a meaningful or statistically significant change from baseline compared to placebo. " but since the weekly infusions arm was stat-sig with p=0.0174 plus secondary endpoints, I think approval is highly likely.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.